Butadiene Epoxide

Butadiene Epoxide

SCHEMBL335040

C=C[C@@H]1CO1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butadiene Epoxide SCHEMBL39877 1.00
Butadiene Epoxide SCHEMBL10496505 0.96
SCHEMBL1559778 0.96 TDP1 (0.93)
SCHEMBL1862726 0.78
SCHEMBL13822490 0.76
SCHEMBL5609192 0.76
Butadiene Epoxide SCHEMBL6067380 0.75 TDP1 (0.56)
SCHEMBL13838050 0.75 TDP1 (0.56)
SCHEMBL5087079 0.74 TDP1 (0.57)
SCHEMBL7697518 0.74 TDP1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118472210-A Preparation method of silicon-carbon-coated anode material 常州硅源新能材料有限公司 2024-08-09 CN claimed
US-12091425-B2 Compounds that inhibit MCL-1 protein AMGEN INC. (US) 2024-09-17 US disclosed
CN-118472210-A Preparation method of silicon-carbon-coated anode material 常州硅源新能材料有限公司 2024-08-09 CN disclosed
CN-112979705-B Nucleotide analogue compound and salt, preparation method and pharmaceutical application thereof 华创合成制药股份有限公司 2024-01-26 CN disclosed
US-20230052348-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2023-02-16 US disclosed
US-20220380309-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2022-12-01 US disclosed
US-11306107-B2 Compounds that inhibit MCL-1 protein AMGEN INC. (US) 2022-04-19 US disclosed
US-20210230189-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2021-07-29 US disclosed
CN-112979705-A Nucleotide analogue compound and salt thereof, preparation method and pharmaceutical application thereof 华创合成制药股份有限公司 2021-06-18 CN disclosed
WO-2020117942-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-11 WO disclosed
US-20140206829-A1 ISOSELECTIVE POLYMERIZATION OF EPOXIDES CORNELL UNIVERSITY (US) 2014-07-24 US disclosed
US-8710283-B2 Isoselective polymerization of epoxides CORNELL UNIVERSITY (US) 2014-04-29 US disclosed
US-20130079491-A1 ISOSELECTIVE POLYMERIZATION OF EPOXIDES CORNELL UNIVERSITY (US) 2013-03-28 US disclosed
US-8097708-B2 10a-Azalide compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-17 US disclosed
EP-2195305-A2 ISOSELECTIVE POLYMERIZATION OF EPOXIDES Cornell Research Foundation, Inc. (US) 2010-06-16 EP disclosed
US-20100144969-A1 ISOSELECTIVE POLYMERIZATION OF EPOXIDES CORNELL UNIVERSITY (US) 2010-06-10 US disclosed
EP-2175495-A1 Sealed device Fujifilm Corporation (JP) 2010-04-14 EP disclosed
US-20090281292-A1 10a-Azalide Compound MEIJI SEIKA PHARMA CO., LTD. (JP) 2009-11-12 US disclosed
WO-2009026261-A2 ISOSELECTIVE POLYMERIZATION OF EPOXIDES CORNELL RESEARCH FOUNDATION, INC. (US) 2009-02-26 WO disclosed
EP-1985620-A1 10a-AZALIDE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2008-10-29 EP disclosed